Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App
International Journal of Clinical Endocrinology and Metabolism · 2018
DOI: 10.17352/ijcem.000031 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Endocrinology and Metabolism, 2018. Verfasst von Saperstein Y und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Diabetes is a major public health issue affecting millions of people in the United States and worldwide. In the United States alone, about 30.3 million people (9.4% of the population) have diabetes [1]. Worldwide, a staggering 422 million have diabetes according to 2014 estimates [2]. Diabetes complications over years of exposure include cardiovascular disease -- stroke and myocardial infarction -- and microvascular disorders -- kidney failure, blindness and amputation [3]. Acute and potentially fatal complications of diabetes include hyperglycemic crises, specifically diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) [4].
Zitieren
APA
Y, S., J, P., & SI, M. (2018). Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App. International Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.17352/ijcem.000031
Vancouver
Y S, J P, SI M. Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App. International Journal of Clinical Endocrinology and Metabolism. 2018. doi:10.17352/ijcem.000031
BibTeX
@article{Y2018,
author = {Y, Saperstein and J, Park and SI, McFarlane},
title = {Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App},
journal = {International Journal of Clinical Endocrinology and Metabolism},
year = {2018},
doi = {10.17352/ijcem.000031}
}
EUVIMED